Target intelligence / Profile preview

RAD9-HUS1-RAD1 interacting nuclear orphan 1 (RHNO1)

Target
RHNO1
Molecular classification
Chromatin-protein adaptor, DNA damage response mediator, Nuclear protein
01

Overview

RAD9-HUS1-RAD1 interacting nuclear orphan 1 (RHNO1) is a nuclear protein that plays a critical role in the DNA damage response (DDR) by serving as an adaptor that interacts with the heterotrimeric RAD9-HUS1-RAD1 (9-1-1) DNA clamp complex. RHNO1 promotes activation of the ATR-CHK1 checkpoint in response to replication stress and is necessary for efficient repair of double-strand DNA breaks via microhomology-mediated end joining (MMEJ) and homologous recombination (HR). It accumulates during mitosis, where it is phosphorylated by Polo-like kinase 1 (PLK1) and recruits polymerase theta (POLQ) for mitotic DNA repair. The N-terminal APSES DNA-binding domain of RHNO1 mediates its interaction with the 9-1-1 complex. Overexpression or dysregulation of RHNO1 is associated with enhanced survival and chemoresistance of cancer cells, and may represent a promising target for therapeutic intervention in tumors that depend on heightened DDR signaling.

Other names
RHNO1RAD9, HUS1, RAD1-interacting nuclear orphan protein 1C12orf32RHINOHKMT1188MGC13204
02

Mechanism of action

Drugs targeting the ATR-CHK1 pathway may indirectly impact RHNO1 function by disrupting checkpoint activation and DNA damage repair. There is interest in targeting the RHNO1-9-1-1 interaction to down-regulate the DNA damage checkpoint in cancer therapy.

03

Biological functions

DNA damage checkpoint activationDNA repair (microhomology-mediated end-joining, MMEJ)DNA repair (homologous recombination, HR)Signal transduction (ATR-CHK1 pathway activation)Regulation of cell cycleProtection against genotoxic stress (e.g., ionizing radiation)
04

Disease associations

Cancer (overexpression linked to poor prognosis and chemotherapy resistance in several cancers such as breast, ovarian, and colorectal cancer)Spondyloepiphyseal Dysplasia, Maroteaux TypeGeleophysic Dysplasia 3
05

Safety considerations

Impairment of normal DNA damage repair functionsImpairment of normal checkpoint functionsPotential for genomic instability in non-cancerous tissuesTherapeutic modulation must balance cancer selectivity with risk of adverse genomic effects
06

Interacting drugs

No clinically approved drugs directly targeting RHNO1

4 more in the full profile.

07

Biomarkers

RHNO1 expression correlated with poor prognosis in cancers (e.g., high-grade serous ovarian cancer, colorectal cancer)RHNO1 expression correlated with resistance to chemotherapy in cancersRHNO1 abundance as a prognostic biomarker for DNA repair-targeted therapiesRHNO1 abundance as a predictive biomarker for DNA repair-targeted therapies

Beyond the preview

Go deeper on RAD9-HUS1-RAD1 interacting nuclear orphan 1 (RHNO1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAD9-HUS1-RAD1 interacting nuclear orphan 1 (RHNO1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call